Showing results (41-50 of 64) with videos related to
Sort By:
Pageof 7
Scandinavian Journal of Immunology|January 1, 1978
Variable-region subgroup and specificity of cold agglutininsW F Riesen, I Majaniemi, H Huser, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1976
The binding of complement by complexes formed between a rabbit antibody and oligosaccharides of increasing sizeJ C Jaton, H Huser, W F Riesen, et al.Atherosclerosis|September 1, 1980
Apoproteins and lipids as discriminators of severity of coronary heart diseaseW F Riesen, R Mordasini, C Salzmann, et al.The Journal of Laboratory and Clinical Medicine|November 18, 2000
Acid-base and endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patientsA Henger, P Tutt, W F Riesen, et al.Clinical Immunology and Immunopathology|June 1, 1987
The proliferative response of human peripheral blood lymphocytes to group A streptococcal vaccineA Morell, U Stoffel-Mazenauer, G Vassalli, et al.Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1981
Studies on retinal microangiopathy and coronary macroangiopathy in rats with streptozotocin-induced diabetesS Waber, V Meister, G L Rossi, et al.Diabetologia|May 1, 1993
Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor IP D Zenobi, P Holzmann, Y Glatz, et al.Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1991
High prevalence of cardiovascular risk factors in the Seychelles (Indian Ocean)P Bovet, C Shamlaye, A Kitua, et al.Cancer Chemotherapy and Pharmacology|August 5, 2010
Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonatesM Joerger, A Templeton, D Köberle, et al.Diabetes Care|October 1, 1991
Antihypertensive therapy with Ca2+. Antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patientsC Ferrier, P Ferrari, P Weidmann, et al.Pageof 7